Open Access

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

Yongjun Wang, Claiborne Johnston, Philip M Bath, Xia Meng, Jing Jing, Xuewei Xie, Anxin Wang, Yuesong Pan, Anding Xu, Qiang Dong, Yilong Wang, Xingquan Zhao, Zixiao Li, Hao Li
DOI: 10.1136/svn-2020-000791 Published 28 June 2021
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

No eLetters have been published for this article.
Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
Yongjun Wang, Claiborne Johnston, Philip M Bath, Xia Meng, Jing Jing, Xuewei Xie, Anxin Wang, Yuesong Pan, Anding Xu, Qiang Dong, Yilong Wang, Xingquan Zhao, Zixiao Li, Hao Li
Stroke and Vascular Neurology Jun 2021, 6 (2) 280-285; DOI: 10.1136/svn-2020-000791
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article